P2X 7 is a subtype of ATP-gated channels that is highly expressed in astrocytes, microglia, and other immune cells. Activation of P2X 7 purinoceptors by ATP or 3Ј-O-(4-benzoyl)-benzoyl ATP (BzATP) induces the formation of cytolytic pores and provokes release of interleukin-1␤ from immune cells. We investigated the actions of other endogenous nucleotides on recombinant and microglial P2X 7 receptors using electrophysiology, fluorescence imaging, and interleukin-1␤ release measurement. We found that initial application of ADP or AMP to Xenopus oocytes expressing P2X 7 receptors was ineffective. However, when ADP and AMP, but not UTP or adenosine, were applied after a brief exposure to ATP or BzATP, they activated P2X 7 receptors in a dose-dependent manner. Moreover, responses to ADP and AMP were also elicited after exposure to low concentrations of ATP and were recorded several minutes after removal of ATP from the extracellular medium. Whole-cell recordings from mouse microglial cells showed that significant responses to ADP and AMP were elicited only after ATP application. YO-PRO-1 dye uptake imaging revealed that, unlike ATP, prolonged application of ADP or AMP did not cause an opening of large cytolytic pores in mouse microglial cells. Finally, ADP and AMP stimulated the release of interleukin-1␤ from ATP-primed mouse and human microglial cells. We conclude that selective sensitization of P2X 7 receptors to ADP and AMP requires priming with ATP. This novel property of P2X 7 leads to activation by ATP metabolites and proinflammatory cytokine release from microglia without cytotoxicity.
Interleukin-1␤ (IL-1␤) is the principal proinflammatory cytokine induced in the brain as a result of systemic or local insult (Hopkins and Rothwell, 1995; Rothwell et al., 1997) . It is readily expressed by microglia and meningeal macrophages within and around the ischemic area after stroke and brain damage (Minami et al., 1992; Liu et al., 1993; Buttini et al., 1994) . Intracerebroventricular injection of the highly selective IL-1 receptor antagonist (Relton and Rothwell, 1992; Garcia et al., 1995) or IL-1␤ antibodies (Yamasaki et al., 1992 (Yamasaki et al., , 1995 significantly reduced cerebral ischemia and neuronal loss in rodents, suggesting a direct role for IL-1␤ in the pathophysiology of stroke. IL-1␤ has also been implicated in several neurodegenerative diseases, such as amyotrophic lateral sclerosis (Pasinelli et al., 1999; Li et al., 2000) , epilepsy (Vezzani et al., 1999 (Vezzani et al., , 2000 , and multiple sclerosis (Martin and Near, 1995; Schijver et al., 1999) . However, IL-1␤ promotes dopaminergic axonal sprouting in the nigrostriatal system, suggesting that it may play a protective role in Parkinson's disease (Ho and Blum, 1997; Nishimura et al., 2000) . In addition to its local actions, IL-1␤ mediates host-defense responses to systemic disease (e.g., infection and inflammation) by altering cardiovascular, immune, and neuroendocrine functions (Hopkins and Rothwell, 1995; Rothwell, 1999) .
Microglia, resident macrophages in the CNS, constitute the major source of IL-1␤ secreted in response to neuronal damage (Giulian et al., 1986; Rothwell, 1999) . Although the mechanisms underlying post-translational processing of IL-1␤ are not fully understood, depletion of cytoplasmic K ϩ has been shown to be crucial for induction of IL-1␤-converting enzyme (ICE) activity and IL-1␤ release (Perregaux and Gabel, 1994) . Extracellular ATP is the only endogenous compound known to cause a significant reduction in intracellular K ϩ and consequent release of IL-1␤ (Perregaux and Gabel, 1994; Sanz and Di Virgilio, 2000) . Substantial evidence currently exists suggesting a key role of P2X 7 ionotropic purinoceptors, nonselective cation channels permeable to K ϩ , Na ϩ , and Ca 2ϩ with widespread distribution in immune cells , in ATP-induced IL-1␤ release. For example, macrophages and microglial cell lines pretreated with oxidized ATP (a P2X 7 antagonist; Ferrari et al., 1997a,b) , microglial cell clones lacking P2X 7 but retaining P2Y receptors (Ferrari et al., 1996) , and macrophages pretreated with a monoclonal anti-P2X 7 antibody (Buell et al., 1998) all failed to induce IL-1␤ release when challenged with ATP. Moreover, ATP failed to induce IL-1␤ release from macrophages expressing mutant P2X 7 receptors, both in vivo and in vitro (Solle et al., 2001) .
Previous studies have shown that ADP (Perregaux and Gabel, 1994; Ferrari et al., 1997b) , but not AMP, UTP, or GTP (Perregaux and Gabel, 1994) , also triggers secretion of significant amounts of IL-1␤ from microglial cells and macrophages. The mechanism underlying the ADP-stimulated IL-1␤ release, however, remains unclear. We describe here a novel functional property of recombinant and microglial P2X 7 receptors by demonstrating their enhanced activation by ADP and AMP after priming with a brief ATP stimulation. Moreover, we show that this change in sensitivity to ADP and AMP is not related to the formation of large cytolytic pores, and that it underlies the ADPand AMP-induced release of IL-1␤ from microglial cells.
MATERIALS AND METHODS
Ooc yte recording. Oocytes were surgically removed from Tricaïne-anesthetized female Xenopus laevis frogs and were incubated with calcium-free Barth's solution containing type I collagenase (1 mg /ml; Life Technologies, Rockville, MD) at room temperature for 2 hr under vigorous agitation. Stage V and V I oocytes were then manually defolliculated before intranuclear microinjection of supercoiled plasmid coding for mouse P2X 7 (mP2X 7 ), rat P2X 7 (rP2X 7 ), and rP2X 2 (5, 1, and 1 ng, respectively). After injection, oocytes were incubated with Barth's solution containing 1.8 mM CaCl 2 at 19°C for 24 -72 hr before electrophysiological recordings.
T wo-electrode voltage-clamp recordings (V H of Ϫ60 mV) were performed using glass pipettes (1-3 M⍀) filled with 3 M KC l solution. Oocytes were placed in a recording chamber and were perf used at a flow rate of 10 -12 ml /min with Ringer's solution, pH 7.4, containing (in mM): NaC l 115, NaOH 5, KC l 2.5, C aC l 2 1.8, and H EPES 10. Membrane currents (DC, 1 kHz) were recorded through an OC -725B amplifier (Warner Instruments, Hamden, C T) and digitized at 500 Hz. Drugs were dissolved in the perf usion solution and applied using a computer-driven valve system. All recordings were made at room temperature.
Patch-clamp recording f rom culture microglial cells. N9 mouse microglial cells (Righi et al., 1989) were cultured in RPM I 1640 medium supplemented with 2 mM glutamine, plated onto 35 mm Petri dishes at a density of 1-5 ϫ 10 5 cells per dish, and incubated at 37°C in 5% CO 2 for 24 -72 hr before electrophysiology and YO-PRO-1 uptake imaging.
Whole-cell voltage-clamp recordings (V H of Ϫ65 mV) were performed using pipettes filled with internal solution, pH 7.15-7.2, containing (in mM): K-gluconate 120, MgC l 2 1, NaOH 4, and H EPES 10 mM. C ells were mounted on the stage of an inverted phase-contrast microscope (Nikon, Tokyo, Japan) and perf used using an SF-77B fast perf usion system (Warner Instruments) at a rate of 1 ml /min. The perf usion solution, pH 7.35, comprised (in mM): NaC l 145, NaOH 5, KC l 3, MgC l 2 1, CaCl 2 0.9, and H EPES 10. Membrane currents (DC, 200 Hz) were recorded through an Axopatch 200B amplifier (Axon Instruments, Foster C ity, CA) and digitized at 500 Hz. All drugs were dissolved in the perf usion solution and delivered using a gravity-controlled fast fluid changer (SF-77B). All experiments were performed at room temperature.
YO-PRO-1 uptak e imag ing. The nucleotide-dependent increase in P2X 7 pore diameter was assessed using YO-PRO-1 (Molecular Probes Inc., Eugene, OR) uptake, a 629 Da propidium di-iodide dye that fluoresces during binding to nucleic acids. Dishes were rinsed twice with the external solution used in electrophysiology to remove the cultured media and were then incubated with external solution containing 1 M YO-PRO-1. Drugs were dissolved in the external solution (containing 1 M YO-PRO-1) and delivered using a fast perf usion system like the one used for electrophysiology. High divalent solution had the same composition as the external solution used for electrophysiology. L ow divalent solution, pH 7.35, comprised (in mM): NaC l 145, NaOH 5, KC l 3, C aC l 2 0.09, and H EPES 10. Fluorescence changes were monitored in single cells (excitation, 491 nm; emission, 509 nm). Images were captured every 30 sec using Axon Imaging Workbench 2.2 software (Axon Instruments) and stored as Axon Imaging files. For priming experiments, ATP (1 mM) was applied for 10 sec, then washed out before application of ADP or AM P. Because nucleotides exhibited different levels of autofluorescence, background fluorescence was subtracted from all images before analysis.
IL-1␤ release assay. Primary cultured microglia from CD1 mice and from patients undergoing neurosurgical treatment for non-tumor-related intractable epilepsy were obtained as described previously by Aloisi et al. (1999) and Yong and Antel (1992) , respectively. Microglial cells were plated onto four well dishes at a density of 3 ϫ 10 5 cells/ well and incubated overnight at 37°C in 5% CO 2 to allow adherence. Lipopolysaccharide (L PS; 1 g /ml) was then added to all wells and incubated for 2 hr before challenge with nucleotides. Hexokinase (10 U/ml with 15 mM glucose) was added during L PS stimulation and then washed out before nucleotide application. Released IL -1␤ (in picograms per 3 ϫ 10 5 cells/ ml) was assayed using mouse or human IL -1␤ ELISA sets (Biosource Inc., C amarillo, CA; PharMingen, San Diego, CA).
Nucleotides. Nucleotides were purchased from Sigma (St. L ouis, MO) and IC N (Santa Mesa, CA). The purity of ADP and AM P was Ͼ98% and Ͼ99%, respectively. The ATP content in individual ADP and AM P lots was 0.0%, as determined by chromatogram. If the ATP content in ADP and AM P products was unknown, we used the enzymatic purification described previously with apyrase for AM P and hexokinase for ADP (Traverso-Cori et al., 1970; Mahaut-Smith et al., 2000) . Briefly, stocks of 10 mM ADP were incubated with 22 mM glucose and 7 U/ml hexokinase at 37°C for 1 hr. Stocks of 10 mM AM P were incubated with 20 U/ml grade III apyrase for 1 hr at 30°C, pH 6.5.
Statistical anal ysis. All values are reported as mean Ϯ SEM. Comparisons of the means between two groups were made using the paired t test.
Comparisons of the means among more than two groups were performed using one-way ANOVA (Sigmastat 2.1; Jandel, San Rafael, CA) followed by T ukey's test for multiple comparisons to identif y specific distinctions. Values were considered significant when p Ͻ 0.05. Sigmoidal and exponential regressions were performed using SigmaPlot 5 software.
RESULTS

Electrophysiological actions of nucleotides on recombinant P2X 7 receptors
During two-electrode voltage-clamp recordings from Xenopus oocytes injected intranuclearly with mP2X 7 cDNA, initial application of 1 mM ADP induced a very small inward current (0.07 Ϯ 0.05 A; n ϭ 11) or had no effect (n ϭ 3). Application of ATP (1 mM) to the same oocytes, however, evoked a large inward current (9.3 Ϯ 0.9 A; n ϭ 14) that recovered rapidly with washing ( Fig.  1 A) . Interestingly, subsequent application of 1 mM ADP, after complete recovery of ATP response, induced a significantly larger inward current (2.97 Ϯ 0.70 A; n ϭ 14; p Ͻ 0.05; paired t test) ( Fig. 1 A) . Initial application of 1 mM AMP induced no current (n ϭ 4) or a very small inward current (0.04 Ϯ 0.03 A; n ϭ 3), but subsequent application, after recovery of ATP response (10.13 Ϯ 1.59 A; n ϭ 7), evoked a larger inward current (0.31 Ϯ 0.24 A; n ϭ 7) ( Fig. 1 B) in all oocytes tested. It was reported previously that responses of megakaryocyte P2X 1 receptors to ADP application were actually a result of ATP contamination of commercial ADP (Mahaut-Smith et al., 2000) . Responses to subsequent application of 1 mM hexokinase-purified ADP (2.95 Ϯ 1.20 A; n ϭ 8) (Fig. 1C ) and 1 mM apyrase-purified AMP (0.24 Ϯ 0.14 A; n ϭ 3) (Fig. 1 D) were larger than their initial responses, and they were comparable in amplitude with those obtained using nonpurified nucleotides. These results indicate that responses of P2X 7 receptors to ADP and AMP are not caused by ATP contamination of commercial nucleotide preparations. Moreover, repeated application of 1 mM ATP did not cause an increase in the amplitude of ATP-evoked current (data not shown).
The actions of ADP and AMP (1 mM each) on mP2X 7 were also investigated before and after application of 300 M 3Ј-O-(4-benzoyl)-benzoyl ATP (BzATP). After complete recovery of a large response induced by BzATP (6.86 Ϯ 0.89 A; n ϭ 4), subsequent application of ADP evoked a significantly larger inward current (2.39 Ϯ 0.75 A; n ϭ 4; p Ͻ 0.05) (Fig. 1 E) than that induced by initial application (0.059 Ϯ 0.044 A; n ϭ 4). In a similar manner, the current amplitude of AMP application to oocytes exposed previously to BzATP (10.6 Ϯ 1.7 A) was significantly larger (1.3 Ϯ 0.4 A; n ϭ 4; p Ͻ 0.05) (Fig. 1 F) than that of initial AMP application (Ͻ0.04 A). These responses were specific to the adenine nucleotides ADP and AMP, because no current response (initial or subsequent) was evoked by adenosine (1-10 mM; n ϭ 11) (Fig. 1G) or by UTP (10-120 M; n ϭ 8) (Fig. 1 H) . Moreover, none of the nucleotides tested induced detectable current responses in water-injected (n ϭ 8) or noninjected (n ϭ 25) oocytes, indicating the absence of endogenous metabotropic or ionotropic receptors activated by extracellular nucleotides (data not shown).
We then investigated the actions of nucleotides on P2X 7 from other species and on other P2X subtypes. In rat P2X 7 -injected oocytes, initial application of 1 mM ADP induced a small inward current (0.19 Ϯ 0.05 A; n ϭ 7) (Fig. 2 A) . After recovery from a current response to 500 M ATP (10.8 Ϯ 1.4 A; n ϭ 7), application of ADP induced a significantly larger inward current (1.27 Ϯ 0.22 A; n ϭ 7; p Ͻ 0.05) (Fig. 2 A) . Responses to subsequent application of 10 mM AMP (0.24 Ϯ 0.11 A; n ϭ 8) were also significantly greater than those obtained during initial application (0.04 Ϯ 0.02 A; n ϭ 8; p Ͻ 0.05) (Fig. 2 B) . We also examined the effects of ADP (100 M) and AMP (500 M) on oocytes expressing the rat P2X 2 receptors, a slowly desensitizing neuronal subtype, before and after application of 50 M ATP. As illustrated in Figure 2C , the current responses to initial (0.71 Ϯ 0.25 A; n ϭ 11) and subsequent (0.95 Ϯ 0.22 A; n ϭ 11) applications of ADP were not statistically different. Likewise, no significant difference was detected between responses to initial (0.04 Ϯ 0.02 A; n ϭ 9) and subsequent (0.09 Ϯ 0.05 A; n ϭ 9) applications of AMP in rat P2X 2 -expressing oocytes (Fig. 2 D) . Therefore, the dramatic potentiation of electrophysiological responses to the nucleotides ADP and AMP after administration of ATP or BzATP seems to be a distinct property of P2X 7 ATPgated channels.
Dose dependency of ADP and AMP responses
Dose-response relationships of the ADP and AMP effects on mP2X 7 receptor channels were determined using the same concentration of each nucleotide 1 min before and 1 min after Figure 3A shows that the current responses to initial ADP application (0.5-10 mM) were undetectable or very small (Ͻ0.1 A). However, application of ADP, after ATP stimulation, induced a robust inward current that clearly increased in amplitude in a dose-dependent manner, with a maximal response achieved at 5 mM and an EC 50 of 1.98 Ϯ 0.12 mM (Fig. 3A,B) . Analogously, current responses to initial application of AMP (1-30 mM) were also undetectable or very small (Ͻ0.06 A) (Fig. 3C) . After ATP stimulation, AMP-induced current displayed a sigmoidal dose-response relationship, with a maximal response achieved at 10 mM and an EC 50 of 4.6 Ϯ 1.1 mM (Fig.  3C,D) . The maximal response obtained with ADP comprised 85 Ϯ 9% of ATP-induced current (I ATP ) and was significantly larger than the maximal response achieved with AMP (43 Ϯ 4% of I ATP ), indicating that both nucleotides are partial agonists for mP2X 7 exposed previously to ATP, with ADP being more potent and more efficacious.
ATP produces a long-lasting priming of P2X 7 receptors
Repeated application of ADP and AMP at their maximal concentrations (5 and 10 mM, respectively) did not induce an increase in the current amplitude (Fig. 4 A,B) . Strikingly, the current responses to ADP and AMP were potentiated after stimulation with low ATP concentrations (e.g., 100 M) (Fig. 4C,D) . As illustrated in Figure 4 E,F, the magnitude of ADP-and AMPinduced currents was dependent on the preceding ATP concentration, reaching maximal levels at saturating ATP concentrations (Ն1 mM). Moreover, after any ATP concentration, the ADP response was much larger than the AMP response. These results indicate that ATP stimulation is necessary to prime P2X 7 receptors for subsequent activation by ADP and AMP.
To test how long P2X 7 receptors remain primed with brief exposure to ATP, ADP and AMP were applied at various intervals after removal of ATP from the extracellular medium. As shown in Figure 5 A,B, significant responses to ADP (5 mM) and The solid line is a nonlinear regression through data points using the three-parameter logistic equation (n H ϭ 2.87 Ϯ 0.49; r ϭ 0.99); the dashed line is a straight line through data points. C, Current responses of mP2X7-expressing oocytes to different concentrations of AMP before ( 1) and after ( 2) application of 1 mM ATP. D, Normalized dose-response curves of AMP-evoked current before (open circles) and after ( filled circles) application of 1 mM ATP. The solid line is a nonlinear regression using the three-parameter logistic equation (n H ϭ 2.79 Ϯ 1.58; r ϭ 0.98). The dashed line is a straight line through data points. Note the absence of a dose-response relationship for ADP or AMP before ATP application. Drugs were applied for 10 sec at 1 min intervals. AMP (10 mM) could still be elicited several minutes after ATP application but at a lesser magnitude (e.g., ADP response at 15 min was 15 Ϯ 8% of I ATP ). Moreover, at any given time, ADP produced a larger response than AMP. The time constant of the ATP priming effect was Ϸ3 min as measured by the exponential decay of the current responses to ADP and AMP (Fig. 5B) . These results indicate that brief exposure to ATP produces a longlasting priming effect on P2X 7 receptor channels during which exposure to either ADP or AMP may produce a notable current response.
Electrophysiological actions of ADP and AMP on microglial cells
P2X 7 ATP-gated channels are highly expressed in microglia and other immune cells . We therefore investigated the electrophysiological actions of ADP and AMP on N9 mouse microglial cells using whole-cell voltage-clamp recording. In agreement with the data obtained in oocytes, initial application of 5 mM ADP induced a small inward current (33 Ϯ 7 pA; n ϭ 8) or no current (n ϭ 3). However, after recovery of the ATP-induced current (361 Ϯ 99 pA; n ϭ 11), application of ADP induced a significantly larger current (170 Ϯ 55 pA; n ϭ 11; p Ͻ 0.05) (Fig.  6 A,B) . Likewise, no current response was elicited with an initial application of 10 mM AMP (n ϭ 5). After return to baseline of ATP-induced current (211 Ϯ 39 pA), application of AMP evoked an inward current (27 Ϯ 4 pA; n ϭ 5; p Ͻ 0.05) (Fig. 6C,D) . Because microglial cells express P2Y metabotropic as well as P2X 7 ionotropic purinoceptors (Wang et al., 1999) , we tested whether P2Y receptors are involved, at least in part, in the enhanced ADP and AMP responses. No significant difference was observed between initial and subsequent ADP-or AMPinduced current recorded before and after application of 10 M UTP (data not shown). Thus, the enhanced ADP and AMP responses in mouse N9 microglial cells are mediated through ATP-primed P2X 7 receptor channels.
ADP and AMP do not cause opening of large pores in microglial cells
Repeated or continuous application of ATP induces formation of large nonselective pores in native and transfected cells expressing P2X 7 receptor channels (Ferrari et al., 1996; Surprenant et al., 1996; Rassendren et al., 1997; Chessell et al., 1998) . We therefore investigated whether ADP and AMP can provoke P2X 7 -mediated pore dilation in N9 mouse microglial cells using YO-PRO-1 uptake imaging. In both high and low divalent solutions, YO-PRO-1 uptake did not increase above background when 1 mM ATP was applied briefly (10 sec) (Fig. 7) . However, the intensity of the dye uptake in response to repeated or continuous application of 1 mM ATP increased significantly over time, with higher uptake measured in low divalent solution (Fig. 7) . In contrast, ADP or AMP, with and without ATP priming, did not induce a significant increase in YO-PRO-1 uptake (Fig. 7) . The dilation of P2X 7 pores in N9 mouse microglial cells, therefore, is specific to prolonged or repeated application of ATP, not ADP or AMP.
ADP and AMP induce IL-1␤ release from ATP-primed microglial cells
Activation of P2X 7 receptor channels by ATP provokes IL-1␤ release from LPS-stimulated microglial cells (Ferrari et al., 1996 (Ferrari et al., , 1997b and macrophages (Ferrari et al., 1997a) . We investigated the effects of ADP and AMP on IL-1␤ release from LPSstimulated (1 g/ml for 2 hr) microglial cells and examined the role of ATP priming in such release.
In N9 mouse microglial cells, IL-1␤ release in response to application of 10 mM AMP (without priming; 131 Ϯ 41 pg/ml; n ϭ 4) was not different from controls (LPS only; 111 Ϯ 55 pg/ml; n ϭ 5). However, AMP, after ATP priming, induced significant IL-1␤ release (347 Ϯ 69 pg/ml; n ϭ 4; p Ͻ 0.05, one-way ANOVA) (Fig. 8 A) . In contrast, ADP (5 mM) without ATP priming produced a significant release of IL-1␤ (445 Ϯ 101 pg/ml; n ϭ 7) that was not different from that obtained after ATP priming (402 Ϯ 51 pg/ml; n ϭ 5) or with ATP alone (413 Ϯ 128 pg/ml; n ϭ 4; p Ͼ 0.05) (Fig. 8 A) . Several cell types, including microglial cells (Ferrari et al., 1997b,c) , release small amounts of ATP after LPS stimulation, leading to the formation of an autocrine loop at the level of P2X 7 receptors. We therefore sought to disrupt this autocrine loop by incubating microglial cells with hexokinase during LPS stimulation to convert endogenously released ATP into ADP. After the hexokinase treatment, ADP failed to provoke IL-1␤ release from N9 microglial cells (46 Ϯ 10 pg/ml; n ϭ 3) (Fig. 8 A) .
In primary cultured mouse microglia, the release of IL-1␤ in response to 10 mM ADP, without experimental ATP priming, was 1120 Ϯ 261 pg/ml (n ϭ 3), which was not different from that obtained after ATP priming (866 Ϯ 33 pg/ml; n ϭ 3) or in response to ATP alone (771 Ϯ 98 pg/ml; n ϭ 3) (Fig. 8 B) . After treatment with hexokinase, however, ADP-induced IL-1␤ release was negligible (76 Ϯ 14 pg/ml; n ϭ 3) (Fig. 8 B) . Similarly, AMP-induced IL-1␤ release without ATP priming (577 Ϯ 106 pg/ml; n ϭ 3) was not different from that evoked by the same agonist after ATP priming (675 Ϯ 30 pg/ml; n ϭ 3). Pretreatment with hexokinase inhibited the AMP-induced IL-1␤ release (68 Ϯ 9 pg/ml; n ϭ 3) (Fig. 8 B) .
In primary cultured human microglia, IL-1␤ release in response to 1 mM ATP was 207 Ϯ 20 pg/ml (n ϭ 3). IL-1␤ release in response to ADP and AMP (10 mM each) was 57 Ϯ 20 pg/ml (n ϭ 3) and 16 Ϯ 8 pg/ml (n ϭ 3), respectively, and was not significantly different from controls (34 Ϯ 7 pg/ml; n ϭ 3) (Fig.  8C) . After ATP priming, both nucleotides provoked significant release of IL-1␤ (152 Ϯ 13 pg/ml, n ϭ 3 for ADP; 113 Ϯ 21 pg/ml, n ϭ 3 for AMP). Thus, ATP priming of microglial cells underlies the ADP-and AMP-induced release of the inflammatory cytokine IL-1␤.
DISCUSSION
Priming P2X 7 with ATP
P2X 7 purinoceptor defines a unique ATP-gated channel subtype with several distinct properties. It displays higher sensitivity to BzATP than to ATP and requires higher ATP concentrations for activation than other P2X receptors (Surprenant et al., 1996; Rassendren et al., 1997; Chessell et al., 1998) . We have shown that stimulation of recombinant and microglial P2X 7 receptors with ATP induces a dramatic increase in their sensitivity to the metabolites ADP and AMP, but not to UTP and adenosine. The fact that repeated application of ADP or AMP did not potentiate their own responses and that enhanced responses to both nucleotides can still be elicited after very low ATP concentrations indicates that ATP selectively primes P2X 7 receptors for activation by ADP or AMP. This dose-dependent priming effect can last several minutes beyond the complete recovery from ATP stimulation. This novel functional property of P2X 7 receptors is not common to all P2X subtypes, because responses of P2X 2 receptors to ADP and AMP were not enhanced after ATP stimulation.
P2X 7 subunits are characterized by the presence of a long C-terminal domain involved in the formation of nonselective pores permeable to solutes as large as 900 Da (Nuttle and Dubyak, 1994; Di Virgilio, 1995; Surprenant et al., 1996; Rassendren et al., 1997) . We therefore thought of a direct relationship between the potentiated responses of P2X 7 receptors to ADP and AMP and the formation of large pores. However, our results demonstrated that both ADP and AMP failed to induce dilation of the pore, either alone or after priming with ATP. Moreover, the pore dilation cannot be achieved after a single brief application of ATP, and it requires repeated or sustained application over several minutes.
ATP priming induced an increase in ADP and AMP potency, clearly demonstrated by the absence of dose-dependent relationships for both nucleotides before ATP stimulation and the presence of sigmoidal dose-response relationships after ATP priming. This dramatic change of sensitivity for ADP and AMP decreased with time. Therefore, ATP stimulation most likely triggers a reversible conformational change of P2X 7 receptor channels leading to modification of the agonist binding domain(s), of the gating properties of the channels, or of both. An increase in ATP potency without P2X 7 pore enlargement was reported previously with repeated application of submaximal ATP concentrations (Hibell et al., 2000) . Activity-dependent phosphorylation or dephosphorylation of P2X 7 receptors is another candidate mechanism for mediating the ATP priming effect. Indeed, the intracellular domains of P2X subunits contain several potential protein kinase sites with functional impact (Koshimizu et al., 1999; Boué-Grabot et al., 2000; Kim et al., 2001) . Alternatively, if this property of priming is not intrinsic to the P2X 7 receptors, it may be conferred on them by a conserved associated protein expressed both in Xenopus oocytes and in microglial cells.
P2X 7 priming and IL-1␤ release
The release of IL-1␤ from immune cells is a two-step process. The first step requires transcription of the IL-1␤ gene and accumulation of pro-IL-1␤ in response to inflammatory stimuli, including bacterial endotoxins (LPS; Rothwell and Luheshi, 2000; Sanz and Di Virgilio, 2000) . The second step involves maturation of IL-1␤ by ICE in preparation for its release (Perregaux and Gabel, 1994; Sanz and Di Virgilio, 2000) . P2X 7 receptor channel activation by ATP plays a critical role in this post-translational processing (Buell et al., 1998; Sanz and Di Virgilio, 2000) . Our results demonstrated that the ADP-induced IL-1␤ release from mouse microglial cells and macrophages reported previously (Perregaux and Gabel, 1994; Ferrari et al., 1997b ) is caused by priming of P2X 7 receptors located on these cells with endogenously released ATP in response to LPS stimulation (Ferrari et al., 1997b,c) , as determined by the absence of ADP-induced IL-1␤ release when hexokinase was present during LPS stimulation (Fig. 8 A,B) . Hexokinase therefore prevents P2X 7 priming by ATP released from microglia. In addition, we demonstrated that priming of microglial cells by ATP (endogenously released or experimentally applied) underlies the release of IL-1␤ in response to AMP. The priming effect of ATP on ADP-and AMPinduced IL-1␤ release was more evident in human microglia, in which both nucleotides were effective only after experimental ATP priming. Moreover, in all preparations, the priming effect of ATP was stronger for ADP than for AMP, as demonstrated by the release of greater amounts of IL-1␤ in response to ADP.
These data are in good agreement with our electrophysiology results (Figs. 3C and 6C,D) , in which ADP and AMP were both ineffective in activating P2X 7 receptors before ATP priming. Moreover, at any given concentration, the priming effect of ATP was more dramatic for ADP than for AMP (Fig. 4C,D) . Thus, ATP priming of P2X 7 receptor channels underlies the ADP-and AMP-induced release of IL-1␤ from microglial cells.
Physiological relevance
The concentration of intracellular ATP falls in the millimolar range (e.g., 5-10 mM; Ferrari et al., 1997c) . Therefore, it is not surprising that significant amounts of ATP can be present in the extracellular space because of cell damage after injury, infection, and ischemia. Extracellular ATP is hydrolyzed into ADP, then AMP, by surface ectonucleotidases, and AMP is converted into adenosine by 5Ј nucleotidase activities (Zimmermann, 2000) . The rate of this hydrolysis cascade depends locally on the expression levels and surface densities of the various ectonucleotidase isoforms displaying different relative affinities for ATP and ADP. For example, CD39 hydrolyzes both ADP and ATP at a similar Figure 8 . Nucleotide-induced IL-1␤ release from LPS-stimulated microglial cells. Released IL-1␤ (mean Ϯ SEM) from N9 mouse microglial cells (A, 2 mM ATP, 5 mM ADP, and 10 mM AMP), primary cultured mouse microglia (B, 2 mM ATP, 10 mM ADP, and 10 mM AMP), and primary cultured human microglia (C, 1 mM ATP, 10 mM ADP, and 10 mM AMP) in response to stimulation with ATP and in response to ADP or AMP with and without previous priming with ATP is shown. pAMP and pADP indicate that cells were primed with ATP for 2 min and then washed twice for 1 min before application of the nucleotide (in LPS-containing medium) for 15 min. pCTR indicates that cells were primed with ATP for 2 min followed by two washes, and then the supernatant was taken at 15 min. ADPϩHexo or AMPϩHexo indicates that cells were stimulated with LPS for 2 hr in the presence of hexokinase and glucose (as a substrate) before washout and addition of the indicated nucleotide for 15 min. *p Ͻ 0.05. Open bars indicate CTR or ATP challenge, solid bars indicate ADP challenge, and gray bars indicate AMP challenge.
